Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF‐1α and VEGF

Retinal neovascularization (NV) occurs in various ocular disorders including proliferative diabetic retinopathy, retinopathy of prematurity and secondary neovascular glaucoma, which often result in blindness. Vascular endothelial growth factor (VEGF) is an essential growth factor for angiogenesis, and is particularly regulated by hypoxia inducible factor‐1α (HIF‐1α) under hypoxic conditions. Therefore, HIF‐1α and VEGF could provide targets for therapeutic intervention on retinal NV. In this study, we investigated the inhibitory effects of small interfering RNA (siRNA) targeting HIF‐1α and VEGF on the expression of HIF‐1α and VEGF in human umbilical vein endothelial cells (HUVEC) in vitro and on retinal NV in vivo. siRNA‐expressing plasmids targeting human HIF‐1α (HIF‐1α siRNA) and human VEGF165 (VEGF siRNA) were constructed. They were transfected and co‐transfected to HUVEC and C57BL/6J mice of ischemic retinopathy model. HIF‐1α siRNA and VEGF siRNA specifically downregulated HIF‐1α and VEGF at both mRNA and protein levels in vitro and in vivo. Neovascular tufts and neovascular nuclei were decreased in gene therapy group compared to control hypoxia group. Co‐transfection of HIF‐1α siRNA and VEGF siRNA resulted in maximal effects on VEGF suppression in vitro and in vivo. It also manifested the maximal inhibitory effect on retinal NV. These results indicate that the application of HIF‐1α siRNA and VEGF siRNA technology holds great potential as a novel therapeutic for retinal NV. J. Cell. Physiol. 218: 66–74, 2009. © 2008 Wiley‐Liss, Inc.

[1]  P. Campochiaro,et al.  Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. , 2000, The American journal of pathology.

[2]  Helen M Blau,et al.  Restriction enzyme–generated siRNA (REGS) vectors and libraries , 2004, Nature Genetics.

[3]  P. Campochiaro,et al.  Ocular neovascularization: a valuable model system , 2003, Oncogene.

[4]  T. Matsuo,et al.  Gene transfer with liposomes to the intraocular tissues by different routes of administration. , 1996, Investigative ophthalmology & visual science.

[5]  Raymond M Schiffelers,et al.  Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. , 2004, The American journal of pathology.

[6]  Jian-xing Ma,et al.  Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy , 2007, Progress in Retinal and Eye Research.

[7]  Gary Ruvkun,et al.  Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes , 2003, Nature.

[8]  Yuichi Makino,et al.  Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3α Locus* , 2002, The Journal of Biological Chemistry.

[9]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[10]  Jian-xing Ma,et al.  Inhibition of Ocular Angiogenesis by Diced Small Interfering RNAs (siRNAs) Specific to Vascular Endothelial Growth Factor (VEGF) , 2006, Current eye research.

[11]  Y. Kondo,et al.  Subcellular localization and regulation of hypoxia-inducible factor-2α in vascular endothelial cells , 2004 .

[12]  Wenbiao Liu,et al.  A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse Model , 2005, Clinical Cancer Research.

[13]  J. Provis,et al.  Development of the human retinal vasculature: cellular relations and VEGF expression. , 1997, Experimental eye research.

[14]  J. Bennett,et al.  Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. , 2003, Molecular vision.

[15]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[16]  P. Sharp,et al.  RNAi Double-Stranded RNA Directs the ATP-Dependent Cleavage of mRNA at 21 to 23 Nucleotide Intervals , 2000, Cell.

[17]  M. Boulton,et al.  Retinal and choroidal microangiopathies: therapeutic opportunities. , 2007, Microvascular research.

[18]  F. Ismail-Beigi,et al.  Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 , 2001, The Journal of Biological Chemistry.

[19]  P. Campochiaro,et al.  Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1 , 2006, Gene Therapy.

[20]  G. Semenza,et al.  Structural and functional analysis of hypoxia-inducible factor 1. , 1997, Kidney international.

[21]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[22]  P. Campochiaro,et al.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. , 1999, Investigative ophthalmology & visual science.

[23]  Yuichi Makino,et al.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.

[24]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  R. Bernards,et al.  A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity , 2005, Cell.

[26]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[27]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[28]  L. Chin,et al.  A Genetic Screen for Candidate Tumor Suppressors Identifies REST , 2005, Cell.

[29]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.

[30]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[31]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[32]  P. Campochiaro,et al.  Vasohibin is up‐regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.